GlassScriptPhysician profile
Yakov Markov Perper
NPI 1841280997
$16,282.53
in general payments reported to CMS, 2019-2025
49 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,525 · 2020: $1,955 · 2021: $1,997 · 2022: $1,400 · 2023: $2,499 · 2024: $5,427 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,319 · Travel and Lodging: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,319.36 |
| Travel and Lodging | $1,086.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $4,025.84 | 2024 | M22 |
| Scilex Pharmaceuticals INC. | $2,111.73 | 2019-2025 | Ztlido |
| Relievant Medsystems, INC. | $1,440.11 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $1,223.05 | 2019-2025 | Xtampza |
| Nevro Corp. | $1,097.09 | 2019-2024 | Senza |
| Abbvie INC. | $800.57 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $628.11 | 2019-2025 | Relistor |
| Horizon Therapeutics Plc | $627.28 | 2019-2022 | |
| Daiichi Sankyo INC. | $402.72 | 2019 | |
| Pfizer INC. | $275.39 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $247.82 | 2019-2022 | |
| Allergan, INC. | $237.15 | 2019-2021 | |
| Medtronic, INC. | $234.19 | 2021-2025 | Inceptiv |
| Ibsa Pharma INC. | $231.37 | 2021-2024 | Tirosint, Licart, Tirosint |
| Biohaven Pharmaceuticals, INC. | $207.79 | 2020-2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yakov Perper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.